Clinical Trial Update: Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing preoperative regimens of trastuzumab with vinorelbine versus docetaxel/carboplatin/trastuzumab in HER2-positive breast cancer, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)
• Taxotere (docetaxel)

Snippet

Sponsor: Eric Winer, MD | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-01-25